#VisualAbstract: Tezepelumab reduced annual exacerbation rates in patients with severe asthma | 2 Minute Medicine
2 Minute Medicine ,
1. Subcutaneous tezepelumab treatment was shown to reduce the rate of annual asthma exacerbations in patients with severe…